Canada Respiratory Devices Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

Canada's respiratory devices market covers therapeutic and monitoring equipment used to deliver oxygen, support ventilation, and manage airway disorders across hospital and home-care settings. The market is estimated at $0.482 billion in 2025 and is projected to grow at a compound annual rate of about 7.43%, reaching materially higher value by the early 2030s. Demand is concentrated in provinces with large elderly populations and well-developed hospital infrastructure, notably Ontario, Quebec, British Columbia, and Alberta.

• •Estimated 2025 market size: approximately USD 0.482 billion with a ~7.43% CAGR through the forecast horizon.
• •Core product categories: PAP devices, ventilators, non-invasive ventilation masks and circuits, and respiratory device accessories.
• •Largest provincial markets: Ontario, Quebec, British Columbia, and Alberta, supported by aging demographics and tertiary hospital networks.

The principal growth driver is the increasing clinical burden of chronic respiratory diseases in Canada, particularly COPD and obstructive sleep apnea, both of which require ongoing device-based therapy. Demographic aging is amplifying this trend, as Canadians over 65 represent the fastest-growing population cohort and the heaviest users of respiratory support. Wider reimbursement coverage for home-based therapies, greater clinician familiarity with non-invasive ventilation, and the legacy of pandemic-era capacity investments are also accelerating equipment uptake.

• •Rising prevalence of COPD, asthma, and obstructive sleep apnea is expanding the addressable patient pool.
• •Canada's aging population is increasing demand for long-term oxygen therapy, PAP devices, and home ventilators.
• •Provincial reimbursement programs and broader home-care coverage are shifting care from hospitals to outpatient and home settings.

By product type, the market is typically segmented into therapeutic devices (PAP machines, ventilators, nebulizers, oxygen concentrators, and inhalers) and diagnostic or monitoring devices such as pulse oximeters and capnographs, with therapeutic devices accounting for the majority share. Masks, circuits, filters, and tubing form a recurring-accessories segment that grows alongside the installed base of devices. Geographically, Ontario and Quebec lead due to population size and the concentration of academic hospitals, while Western Canada is the fastest-growing region as community hospitals in Alberta and British Columbia expand respiratory services.

• •Therapeutic devices dominate revenue share, supported by recurring demand for masks, circuits, and filters.
• •PAP devices and home ventilators are the fastest-growing sub-segments, driven by sleep apnea diagnosis and home-care trends.
• •Ontario and Quebec lead consumption; Alberta and British Columbia show the strongest incremental growth.

What are the recent trends and outlook?

The most visible trend is the continued migration of respiratory care into the home, supported by miniaturized portable ventilators, integrated humidification, and cloud-connected PAP devices that enable remote monitoring by clinicians. Manufacturers are also investing in smart sensors and telehealth-compatible platforms to differentiate offerings and support value-based care models. Over the forecast period, the market is expected to sustain mid-to-high single-digit growth, with the strongest gains in home-care devices, accessories tied to the installed base, and digital-enabled ventilation platforms.

• •Home-care and portable respiratory devices are outpacing hospital equipment growth.
• •Connectivity, remote monitoring, and telehealth integration are emerging as key product differentiators.
• •Outlook points to sustained expansion, anchored by chronic disease prevalence, aging demographics, and ongoing technology upgrades.